CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-28 | Cumbo Alexander EVP, Chief Commercial Officer | Grant or award | +6,700 | 8,567 | ||
| 2020-02-28 | Cumbo Alexander EVP, Chief Commercial Officer | Grant or award · Stock option (right to buy) | +37,500 | 37,500 | ||
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Exercise or conversion | +2,727 | $13.71 | $37K | 13,888 |
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Exercise or conversion | +3,895 | $13.71 | $53K | 17,783 |
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Exercise or conversion | +26,084 | $26.24 | $684K | 43,867 |
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Sale | −32,706 | $125.50 | $4.1M | 11,161 |
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Sale | −9,294 | $125.50 | $1.2M | 1,867 |
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −2,727 | 1,123 | ||
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −3,895 | 0 | ||
| 2019-12-13 | Cumbo Alexander EVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −26,084 | 20,881 | ||
| 2019-03-28 | Cumbo Alexander EVP, Chief Commercial Officer | Grant or award | +4,876 | 13,326 | ||
| 2019-03-28 | Cumbo Alexander EVP, Chief Commercial Officer | Shares withheld for taxes | −2,165 | $118.68 | $257K | 11,161 |
| 2019-03-04 | Cumbo Alexander EVP, Chief Commercial Officer | Grant or award · Stock option (right to buy) | +45,000 | 45,000 | ||
| 2019-02-28 | Cumbo Alexander EVP, Chief Commercial Officer | Returned to the company | −3,375 | 8,450 | ||
| 2019-02-01 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion | +2,250 | $13.90 | $31K | 25,016 |
| 2019-02-01 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion | +5,250 | $26.24 | $138K | 30,266 |
| 2019-02-01 | Cumbo Alexander SVP, Chief Commercial Officer | Sale | −15,000 | $140.00 | $2.1M | 15,266 |
| 2019-02-01 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) | −2,250 | 0 | ||
| 2019-02-01 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Stock Option (right to buy) | −5,250 | 46,965 | ||
| 2018-08-08 | Cumbo Alexander SVP, Chief Commercial Officer | Shares withheld for taxes | −6,000 | $121.02 | $726K | 22,766 |
Page 1 of 3 · 45 trades